GlassScriptPhysician profile
Gregory D Crenshaw
NPI 1326238171
$66,905.21
in general payments reported to CMS, 2019-2025
21 companies · $26K in 2025
The $26K reported for 2025 was more than what 95% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $845 · 2020: $186 · 2021: $4,384 · 2022: $2,648 · 2023: $15K · 2024: $18K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $55K · Consulting Fee: $3,150 · Food and Beverage: $859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $54,833.33 |
| Consulting Fee | $3,150.00 |
| Food and Beverage | $859.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $56,558.92 | 2019-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Venacure 1470 Pro |
| Bard Peripheral Vascular, INC. | $3,575.38 | 2020-2025 | Pristine |
| Medtronic, INC. | $2,711.13 | 2021-2023 | Chameleon, Ellipsys Vascular Access System |
| Janssen Pharmaceuticals, INC | $1,025.16 | 2019-2021 | |
| Philips North America LLC | $793.48 | 2019-2024 | (Bu1) Laser Serv and Other Undivided |
| Biom'Up France Sas | $569.55 | 2021 | |
| Ethicon US, LLC | $194.85 | 2019 | |
| Cardiovascular Systems INC. | $155.69 | 2019-2022 | |
| Stryker Corporation | $153.81 | 2021 | |
| Dilon Technologies, INC. | $149.31 | 2024 | Hemoblast Bellows |
| Si-Bone, INC. | $149.28 | 2019 | |
| Acera Surgical, INC. | $127.79 | 2025 | Restrata Wound Matrix |
| Abbott Laboratories | $125.97 | 2020-2023 | Diamondback Peripheral |
| Aurinia Pharma U.S., INC. | $124.99 | 2021 | |
| Penumbra, INC. | $124.29 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $108.01 | 2024 | |
| Mozarc Medical US LLC | $91.46 | 2024 | Palindrome |
| Cordis US Corp. | $69.55 | 2022-2023 | Saber |
| Boston Scientific Corporation | $54.28 | 2024-2025 | Varithena Administration Pack |
| Smith+Nephew, INC. | $23.12 | 2021 | |
| Argon Medical Devices, INC. | $19.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Crenshaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.